Antibodies have long been regarded as the only class of binding proteins. With the emergence of protein engineering techniques, new binding proteins based on alternative scaffolds have been designed. Additionally, modern technologies for selection and evolution from libraries are independent of the antibody scaffold and could thus be readily used for obtaining specific binding proteins. One important group of alternative scaffolds is based on repeat proteins. Nature is widely using these proteins to modulate protein-protein interactions, and even in the adaptive immune system of jawless vertebrates; the step to their application as an alternative to antibodies seems therefore logical. In this review, progress on DARPins and other repeat pro...
Protein-protein interactions are crucial for cellular homeostasis and play important roles in the dy...
Developmental biology research would benefit greatly from tools that enable protein function to be r...
The number of therapeutic antibodies in preclinical, clinical, or approved phases has been increasin...
Antibodies have long been regarded as the only class of binding proteins. With the emergence of prot...
Specific binding proteins have become essential for diagnostic and therapeutic applications, and tra...
Nonimmunoglobulin scaffolds have been developed to overcome the limitations of monoclonal antibodies...
Antibodies are the most versatile binding proteins in nature with six loops creating a flexible cont...
Designed ankyrin repeat proteins (DARPins) can recognize targets with specificities and affinities t...
Protein-protein interactions are crucial to almost all biological processes. Studying such interacti...
Proteins, large biological molecules synthesized by living organisms, serve a wide array of function...
Designed ankyrin repeat proteins (DARPins) are engineered proteins comprising consensus designed ank...
Multivalent binding proteins can gain biological activities beyond what is inherent in the individua...
Designed ankyrin repeat proteins (DARPins) are artificial binding proteins that have found many uses...
The specific recognition of peptides, which we define to include unstructured regions or denatured f...
Several binding scaffolds that are not based on immunoglobulins have been designed as alternatives t...
Protein-protein interactions are crucial for cellular homeostasis and play important roles in the dy...
Developmental biology research would benefit greatly from tools that enable protein function to be r...
The number of therapeutic antibodies in preclinical, clinical, or approved phases has been increasin...
Antibodies have long been regarded as the only class of binding proteins. With the emergence of prot...
Specific binding proteins have become essential for diagnostic and therapeutic applications, and tra...
Nonimmunoglobulin scaffolds have been developed to overcome the limitations of monoclonal antibodies...
Antibodies are the most versatile binding proteins in nature with six loops creating a flexible cont...
Designed ankyrin repeat proteins (DARPins) can recognize targets with specificities and affinities t...
Protein-protein interactions are crucial to almost all biological processes. Studying such interacti...
Proteins, large biological molecules synthesized by living organisms, serve a wide array of function...
Designed ankyrin repeat proteins (DARPins) are engineered proteins comprising consensus designed ank...
Multivalent binding proteins can gain biological activities beyond what is inherent in the individua...
Designed ankyrin repeat proteins (DARPins) are artificial binding proteins that have found many uses...
The specific recognition of peptides, which we define to include unstructured regions or denatured f...
Several binding scaffolds that are not based on immunoglobulins have been designed as alternatives t...
Protein-protein interactions are crucial for cellular homeostasis and play important roles in the dy...
Developmental biology research would benefit greatly from tools that enable protein function to be r...
The number of therapeutic antibodies in preclinical, clinical, or approved phases has been increasin...